Molecular Biology of Cancer, Oncogenes, and Stem Cell Therapeutics
Curriculum and historical examination lineage for Molecular Biology of Cancer, Oncogenes, and Stem Cell Therapeutics under Unit 5 (Cell Regulation, Cancer, and Stem Cells) of Cell Biology (21BTC102J) at SRMIST.
Historical appearance distribution across SRMIST Formative Tests (CT1, CT2) and University End Semester examinations.
Factual marks weightage of questions asked on this topic in historical examinations.
Question templates that recur across multiple examination cycles with similar conceptual stems.
“Which of the following cancer is of Mesenchymal origin? (A) Squamous cell carcinoma (B)...”
“Aromatase inhibitors blocks the production of ___ (A) Progesterone (B) Estrogen (C) Thyroid (D)...”
“The LCIS represents ___ stage of breast cancer. (A) 0 (B) 1 (C) 2 (D) 3”
“Which of the following is not a hallmark of cancer? (A) Inducing apoptosis (B) Evasion of growth...”
“Discuss the Etiology, stages, diagnosis, and treatment of lung cancer.”
Representative historical questions extracted directly from SRMIST examination papers.
Which of the following cancer is of Mesenchymal origin? (A) Squamous cell carcinoma (B) Adenocarcinoma (C) Sarcoma (D) Leukemia
Aromatase inhibitors blocks the production of ___ (A) Progesterone (B) Estrogen (C) Thyroid (D) Insulin
The LCIS represents ___ stage of breast cancer. (A) 0 (B) 1 (C) 2 (D) 3
Which of the following is not a hallmark of cancer? (A) Inducing apoptosis (B) Evasion of growth inhibitory signals (C) Angiogenesis (D) Growth signal autonomy
Discuss the Etiology, stages, diagnosis, and treatment of lung cancer.
Examinations where questions for Molecular Biology of Cancer, Oncogenes, and Stem Cell Therapeutics have appeared.
Master Molecular Biology of Cancer, Oncogenes, and Stem Cell Therapeutics in MintAI
Practice past exam questions, test recurring archetypes, and view predictive probability for this topic before your upcoming exam.